Curating the way to better determinants of genetic risk

New England Journal of Medicine

Volumn 372, Issue 23, 2015, Pages 2227-2228

  Phimister, Elizabeth G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

BRCA2 GENE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; EDITORIAL; GENE; GENE SEQUENCE; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MRE11A GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; STANDARDS;

BREAST NEOPLASMS; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; HUMANS;

EID: 84930531795     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1506276     Document Type: Editorial

References (5)

1. Rebbeck TR, Mitra N, Wan F, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 2015;313:1347-61.
2. Jhuraney A, Velkova A, Johnson RC, et al. BRCA1 Circos: a visualisation resource for functional analysis of missense variants. J Med Genet 2015;52:224-30.
3. Rehm HL, Berg JS, Brooks LD, et al. ClinGen - the clinical genome resource. N Engl J Med 2015;372:2235-42.
4. Easton DF, Pharoah PDP, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 2015;372:2243-57.
5. Evans BJ, Burke W, Jarvik GP. The FDA and genomic tests - getting regulation right. N Engl J Med 2015;372:2258-64.